2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide

C32H29N7O — CID 137111562

IUPAC2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
SMILESO=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)ccnc5[nH]4)c3c2)c1
InChIInChI=1S/C32H29N7O/c40-30(14-20-6-2-1-3-7-20)36-23-15-22(18-33-19-23)21-9-10-28-26(16-21)31(39-38-28)29-17-25-24(11-13-35-32(25)37-29)27-8-4-5-12-34-27/h4-5,8-13,15-20H,1-3,6-7,14H2,(H,35,37)(H,36,40)(H,38,39)
InChIKeyCLSRHFULEOVCSE-UHFFFAOYSA-N
MW527.63 g/mol
LogP7.14
Rot. Bonds6

About 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide

2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide (PubChem CID 137111562) has the molecular formula C32H29N7O and a molecular weight of 527.63 g/mol. Its IUPAC name is 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide.

Molecular Properties

Compound Name2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
PubChem CID137111562
Molecular FormulaC32H29N7O
Molecular Weight527.63 g/mol
Exact Mass527.24
IUPAC Name2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide
SMILESO=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)ccnc5[nH]4)c3c2)c1
InChIInChI=1S/C32H29N7O/c40-30(14-20-6-2-1-3-7-20)36-23-15-22(18-33-19-23)21-9-10-28-26(16-21)31(39-38-28)29-17-25-24(11-13-35-32(25)37-29)27-8-4-5-12-34-27/h4-5,8-13,15-20H,1-3,6-7,14H2,(H,35,37)(H,36,40)(H,38,39)
InChIKeyCLSRHFULEOVCSE-UHFFFAOYSA-N
XLogP7.14
TPSA112.24 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.63
LogP ≤ 57.14
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The IUPAC name of 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide (CID 137111562) is 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide.
What is the SMILES notation for 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The canonical SMILES for 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide is O=C(CC1CCCCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)ccnc5[nH]4)c3c2)c1.
What is the InChIKey of 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
The InChIKey is CLSRHFULEOVCSE-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H29N7O/c40-30(14-20-6-2-1-3-7-20)36-23-15-22(18-33-19-23)21-9-10-28-26(16-21)31(39-38-28)29-17-25-24(11-13-35-32(25)37-29)27-8-4-5-12-34-27/h4-5,8-13,15-20H,1-3,6-7,14H2,(H,35,37)(H,36,40)(H,38,39).
What are the key properties of 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide?
2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide has a molecular weight of 527.63 g/mol, XLogP of 7.14, 6 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclohexyl-N-[5-[3-(4-pyridin-2-yl-1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]acetamide is sourced from PubChem (CID 137111562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).